24 /100
LOW RISK
Score updated May 29, 2026

IPHA — Innate Pharma S.A. Dilution Risk Tracker

Track IPHA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IPHA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
40
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛅
Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.52 approaching $1 threshold
🔔 Track IPHA — Get forecast alerts →

💹 Market Data

Market Cap$163.39M
Shares Outstanding93.90M
Float65.91M
Cash$39.93M
Debt$26.27M
Short InterestN/A

🏛 Institutional Holdings

0.2% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track IPHA for full holder detail →

📉 Short Interest

Short Interest90.5K
Days to Cover3.9
% of Float0.1%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track IPHA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IPHA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADM
🔬 More Research for IPHA
📊 IPHA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 IPHA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.